Información del artículo
El Texto completo está disponible en PDF
References
[1.]
R.H. Bartlett.
Extracorporeal life support for cardiopulmonary failure.
Curr Probl Surg, 27 (1990), pp. 621-705
[2.]
R.H. Bartlett, D.W. Roloff, R.G. Cornell, A.F. Andrews, P.W. Dillon, J.B. Zwischenberger.
Extracorporeal circulation in neonatal respiratory failure: A prospective randomized study.
Pediatrics, 76 (1985), pp. 479-487
[3.]
P.P. O'Rourke, R.K. Crone, J.P. Vacanti, J.H. Ware, C.W. Lillehei, R.B. Parada, et al.
Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension: A prospective randomized study.
Pediatrics, 84 (1989), pp. 957-963
[4.]
UK collaborative ECMO Trial Group: UK collaborative randomized trial of neonatal extracorporeal membrane oxygenation.
Lancet, 348 (1996), pp. 75-82
[5.]
B.J. Roy, P. Rycus, S.A. Conrad, R.H. Clark.
The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the extracorporeal life support organization(ELSO) registry.
Pediatrics, 106 (2000), pp. 1334-1338
[6.]
A.H. Jobe.
Pulmonary surfactant therapy.
N Engl J Med, 328 (1993), pp. 861-868
[7.]
R.D. Findlay, H.W. Taeusch, F.J. Walther.
Surfactant replacement therapy for meconium aspiration syndrome.
Pediatrics, 97 (1996), pp. 48-52
[8.]
A. Lotze, B.R. Mitchell, D.I. Bulas, E.M. Zola, R.A. Shalwitz, J.H. Gunkel.
Multicenter study of surfactant (beractant) use in the treatment of term infants with severe respiratory failure.
J Pediatr, 132 (1998), pp. 40-47
[9.]
R.H. Clark, B.A. Yoder, L.L. Sell.
Prospective, randomized comparison of high-frequency oscillation and conventional ventilationin candidates for extracorporeal membrane oxygenation.
JPediatr, 124 (1994), pp. 427-430
[10.]
V. Varnholt, P. Lasch, G. Suske, W. Kachel, W. Brands.
High-frequencyoscillatory ventilation and extracorporeal membrane oxygenation in severe persistent pulmonary hypertension of the newborn.
Eur J Pediatr, 151 (1992), pp. 769-774
[11.]
Y. Ito, T. Kawano, K. Miyasaka, M. Katayama, H. Sakai.
Alternative treatment may lower the need for use of extracorporeal membrane oxygenation.
Acta Pediatr JPN, 36 (1994), pp. 673-677
[12.]
S.H. Abman, B.A. Chatfield, S.L. Hall, I.F. McMurtry.
Role of endothelium-derived relaxing factor during transition of pulmonary circulation at birth.
Am J Physiol, 259 (1990), pp. H1921-H1927
[13.]
J.P. Kinsella, J.A. McQueston, A.A. Rosenberg, S.H. Abman.
Hemodynamic effects of exogenous nitric oxide in ovine transitional pulmonary circulation.
Am J Physiol, 263 (1992), pp. 875-880
[14.]
T. Perreault, J. De Marte.
Maturational changes in endothelium-derived relaxations in the newborn piglet pulmonary circulation.
Am J Physiol, 264 (1993), pp. 302-309
[15.]
S. Moncada, R.M. Palmer, E.A. Higgs.
Nitric oxide: physiology, pathophysiology, and pharmacology.
Pharmacol Rev, 43 (1991), pp. 109-142
[16.]
S. Moncada, A. Higgs.
The L-arginine-nitric oxide pathway.
NEngl J Med, 329 (1993), pp. 2002-2012
[17.]
R.H. Steinhorn, F.C. Morin III, J.R. Fineman.
Models of persistent pulmonary hypertension of the newborn (PPHN) and the role of cyclic guanosine monophosphate (GMP) in pulmonary vasorelaxation.
Semin Perinatol, 21 (1997), pp. 393-408
[18.]
J.W. Berkenbosch, J. Baribeau, T. Perreault.
Decreased synthesis and vasodilation to nitric oxide in piglets with hypoxia-induced pulmonary hypertension.
Am J Physiol, 278 (2000), pp. L276-L283
[19.]
J.D. Roberts Jr., J.R. Fineman, F.C. Morrin 3rd, P.W. Shaul, S. Rimar, M.D. Schreiber, et al.
Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The inhaled nitric oxide study group.
N Engl J Med, 336 (1997), pp. 605-610
[20.]
The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure.
N Engl J Med, 336 (1997), pp. 597-604
[21.]
R.H. Clark, T.J. Kueser, M.W. Walker, W.M. Southgate, J.L. Huckaby, J.A. Perez, et al.
Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn.
N Engl J Med, 342 (2000), pp. 469-474
[22.]
The Neonatal Inhaled Nitric Oxide Study Group. Inhaled nitricoxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia.
Pediatrics, 99 (1997), pp. 838-845
[23.]
J.P. Kinsella, W.E. Truog, W.F. Walsh, R.N. Goldberg, E. Bancalari, D.E. Mayock, et al.
Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation insevere, persistent pulmonary hypertension of the newborn.
JPediatr, 131 (1997), pp. 55-62
[24.]
R. De Lemos, B. Yoder, D. McCurnin, J. Kinsella, R. Clark, D. Null.
The use of high-frequency oscillatory ventilation (HFOV) and extracorporeal membrane oxygenation (ECMO) in the managementof the term/near term infant with respiratory failure.
Early Hum Dev, 29 (1992), pp. 299-303
[25.]
G.M. Hoffman, G.A. Ross, S.E. Day, T.B. Rice, L.D. Nelin.
Inhalednitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn.
Crit Care Med, 25 (1997), pp. 352-359
[26.]
W. Muller, W. Kachel, P. Lasch, V. Varnholt, S.A. Konig.
Inhalednitric oxide for avoidance of extracorporeal membrane oxygenation in the treatment of severe persistent pulmonary hypertension of the newborn.
Intensive Care Med, 22 (1996), pp. 71-76
[27.]
H. Kossel, K. Bauer, G. Kewitz, S. Karaca, H. Versmold.
Do we need new indications for ECMO in neonates pretreated withhigh-frequency ventilation and/or inhaled nitric oxide?.
IntensiveCare Med, 26 (2000), pp. 1489-1495
[28.]
B.S. Gill, H.L. Neville, A.M. Khan, C.S. Cox Jr., K.P. Lally.
Delayed institutionof extracorporeal membrane oxygenation is associated with increased mortality rate and prolonged hospital stay.
JPediatr Surg, 37 (2002), pp. 7-10
[29.]
J.M. Wilson, L.K. Bower, J.E. Thompson, D.O. Fauza, J.C. Fackler.
ECMO in evolution: The impact of changing patient demographics and alternative therapies on ECMO.
J Pediatr Surg, 31 (1996), pp. 1116-1122
[30.]
S. Baumgart, R.B. Hirschl, S.Z. Butler, C.E. Coburn, A.R. Spitzer.
Diagnosis-related criteria in the consideration of extracorporeal membrane oxygenation in neonates previously treated with high-frequency jet ventilation.
Pediatrics, 89 (1992), pp. 491-494
[31.]
M.M.S. Paranka, R.H. Clark, B.A. Yoder, D.M. Null Jr..
Predictors of failure of high-frequency oscillatory ventilation in term infants with severe respiratory failure.
Pediatrics, 95 (1995), pp. 400-404
[32.]
K. Rais-Bahrami, A.E. Wagner, C. Coffman, P. Glass, B.L. Short.
Neurodevelopmentaloutcome in ECMO vs near-miss ECMO patients at 5 years of age.
Clin Pediatr, 39 (2000), pp. 145-152
[33.]
The congenital diaphragmatic hernia study group: Does extracorporeal membrane oxygenation improve survival in neonateswith congenital diaphragmatic herniaα.
J Pediatr Surg, 34 (1999), pp. 720-725
[34.]
R.H. Clark, W.D. Hardin Jr., R.B. Hirschl, T. Jaksie, K.P. Lally, M.R. Langham.
Current surgical management of congenital diaphragmatic hernia study group.
J Pediatr Surg, 33 (1998), pp. 1004-1009
[35.]
C.A. Reickert, R.B. Hirschl, J.B. Atkinson, G. Dudell, K. Georgeson, P. Glick, et al.
Congenital diaphragmatic hernia survival and use of extracorporeal life support at selected level III nurseries with multimodality support.
Surgery, 123 (1998), pp. 305-310
[36.]
D.W. Kays, M.R. Langham, D.J. Ledbetter, J.L. Talbert.
Detrimental effects of standard medical therapy in congenital diaphragmatichernia.
Ann Surg, 230 (1999), pp. 340-351
[37.]
K. Azarow, A. Messineo, R. Pearl, R. Filler, G. Barker, D. Bohn.
Congenital diaphragmatic hernia - A tale of two cities: TheToronto experience.
J Pediatr Surg, 32 (1997), pp. 395-400
[38.]
J.M. Wilson, D.P. Lund, C.W. Lillehei, J.P. Vacanti.
Congenital diaphragmatichernia – A tale of two cities: The Boston experience.
J Pediatr Surg, 32 (1997), pp. 401-405
[39.]
J. Boloker, D.A. Bateman, J.T. Wung, C.J.H. Stolar.
Congenital diaphragmatic hernia in 120 infants treated consecutively with permissive hypercapnea/spontaneous respiration/elective repair.
JPediatr Surg, 37 (2002), pp. 357-366
[40.]
J.P. Kinsella, J. Griebel, J.M. Schmidt, S.H. Abman.
Use of inhalednitric oxide during interhospital transport of newborns with hypoxemic respiratory failure.
Pediatrics, 109 (2002), pp. 158-161
Copyright © 2002. Asociación Española de Pediatría
